View Latest Issue
Washington, DC—Researchers have customized a software suite to automatically determine the disease severity in patients with rheumatoid arthritis (RA) based on information from their electronic medical records (EMRs). This is a solid first step toward streamlining and individualizing diagnosis and treatment of this condition, according to the investigators.
To simplify the process of identifying patients who have osteoporosis or are at elevated risk of the common condition, a company has created the Osteoporosis Advisor.
Uptake of the Centers for Disease Control and Prevention–recommended human papilloma virus (HPV) vaccine is low in the general population, and a new study suggests that it is even lower among children and young adults with autoimmune diseases such as lupus, psoriatic arthritis, and inflammatory bowel disease.
Contemporary guidelines for the management of osteoarthritis (OA) from different stakeholder organizations are generally consistent, according to a systematic review of the literature undertaken as an initiative of the Chronic Osteoarthritis Management Initiative Work Group.
Many nurse practitioners (NPs) and physician assistants (PAs) working in rheumatology clinics appear ready and willing to diagnose and treat rheumatoid arthritis (RA), according to a recently published survey. The results may pinpoint a key to preventing the projected shortfall in rheumatologists in the near future, the researchers suggest.
The US Food and Drug Administration approved the use of apremilast (Otezla), a phosphodiesterase-4 inhibitor, on March 21, 2014, for the treatment of adults with active psoriatic arthritis.
Whistler, BC—An observational study confirms in a real-world setting that people with rheumatoid arthritis (RA) who have low disease activity (LDA) after 6 months of biologic treatment are very likely to achieve remission within the next 6 months.
Whistler, BC—A Toronto team has succeeded in completely tapering three-quarters of the patients with whom they attempted this discontinuation of immunosuppressants. Their analysis suggests immunosuppressant tapering is most likely to succeed in patients who are in clinical remission, who are on a low dose of corticosteroids, and who are tapered slowly.
As the clocked ticked down to midnight on March 31, many Americans rushed to enroll in health in­surance plans made available to them through the Afford­able Care Act (ACA). Ap­proxi­mately 4.2 million people had selected a Market-place plan as of March 1, 2014, less than half of the 8.8 million who have been deemed eligible, and 60% of the 7 million people the Congress­ional Budget Office projected for this timeframe.
Treatment for a life long condition such as rheumatoid arthritis (RA) is a significant part of the costs incurred by patients, but costs such as travel time and associated expenditures are also substantial costs incurred by these patients.
Page 1 of 3
Results 1 - 10 of 28
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology